Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-06-04
1992-11-24
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 12, 514 21, A61K 3764
Patent
active
051661349
ABSTRACT:
A method for the prophylaxis or direct treatment of allergic rhinitis which comprises nasally administering to a patient an effective amount of a serine protease inhibitor which inhibits mast cells, neutrophiles or T-cells or binds with their mediators.
REFERENCES:
patent: 4636489 (1987-01-01), Seemuller et al.
patent: 4732973 (1988-03-01), Barr et al.
patent: 4857314 (1989-08-01), O'Connor et al.
patent: 4916117 (1990-04-01), Lezdey et al.
patent: 5008242 (1991-04-01), Lezdey et al.
Hubbard et al, Biochemical Efficacy and Safety of Monthly Augmentation Therapy for Alpha 1-Antitrypsin Deficiency-Sep. 2, 1988-vol. 260, No. 9.
Lezdey John
Wachter Allan J.
Lezdey John
Schain Howard E.
LandOfFree
Treatment of allergic rhinitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of allergic rhinitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of allergic rhinitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-921706